BCL2L11 and non-small cell lung carcinoma: In this collaborative study, we used individual patient data from published and unpublished studies to perform a meta-analysis on the effect of the BIM polymorphism on PFS and OS in EGFR-TKI-treated NSCLC patients as the primary aim.